A U.S. researcher on Wednesday told a House panel that he “presumes” Russia has an active biological weapons program, Time magazine reported.
Milton Leitenberg, a University of Maryland senior scholar focusing on biological arms, told the House Foreign Affairs Subcommittee on Europe that Russia does not permit outside inspections of three of its scientific facilities. As a result, he said it is not possible to know the current status of the country’s biological weapons program.
“We don’t know what they’re doing,” the arms control specialist said. “They may or may not have an active offensive program — I presume they do.”
Leitenberg noted that the U.S. government does not assess Russia to be “producing and stockpiling [biological] agent any more.”
With the fall of the Soviet Union, Russia assumed control of much of its biological weapons-related infrastructure. Moscow says it does not retain a biological arsenal and is not conducting any research into offensive uses for pathogens. However, a 2012 essay by President Vladimir Putin raised concerns that he foresees the development of a new class of biological arms made to be extra potent through genetic modification.
Russia’s recent incursion into Ukraine has caused tensions with the West to spike to their highest point since the end of the Cold War. With the uptick in tensions, old worries have returned about Russia’s weapons of mass destruction capabilities.
Moscow is a member of the Biological Weapons Convention. However the BWC accord does not have a mechanism for ensuring that signatories are in compliance with the treaty’s prohibition against the creation, production and possession of lethal pathogens — such as smallpox and anthrax strains — that have been modified so they can be disseminated on a large scale.
Amy Smithson, a senior fellow with the James Martin Center for Nonproliferation Studies, said it is feasible to find out about a nation’s potential biological weapon activities even without an enforcement mechanism in the treaty. She pointed to the efforts of U.N. weapon inspectors in Iraq after the first Gulf War, which resulted in Baghdad being forced to acknowledge its work on chemical and biological arms.
What We're Following See More »
The nonpartisan Congressional Budget Office has released its score of the House-passed American Health Care Act, which would replace Obamacare. According to the CBO, the bill would reduce the deficit by $119 billion by 2026, while leaving 14 million more Americans uninsured in 2018 than under current law, a number swelling to 23 million by 2026. Further, insurance premiums would balloon 20 percent in 2018 and five percent in 2019 before the waiver provision in the legislation would kick in. The provision allows states to apply for waivers and permit insurers to offer skimpier plans, which would likely entice younger and healthier individuals to buy health insurance while potentially pricing older and less healthy Americans out of insurance plans. House Republicans approved this bill in late April without waiting for the CBO score.
Republican Sen. Lindsey Graham said Wednesday during a Senate Appropriations subcommittee hearing that President Donald Trump's budget is little more than recycling bin material. "The budget proposed by the president doesn't have a snowball's chance in hell of passing," Graham said. Graham had previously opposed the budget over its nearly 30 percent cut to the budget of the State Department. The budget slashes spending on domestic priorities while increasing military spending.
Senate Majority Leader Mitch McConnell said Wednesday that he doesn't yet know the formula towards gaining passage of an Obamacare replacement in the Senate. "I don't know how we get to 50 (votes) at the moment. But that's the goal," McConnell said. The House passed an Obamacare replacement bill which has been widely seen as dead on arrival in the Senate, and McConnell has put together a working group of Republican Senators working towards creating health care legislation which could gain the support of at least 50 Senators.
"Former FBI Director Robert Mueller has been cleared by U.S. Department of Justice ethics experts to oversee an investigation into possible collusion between then-candidate Donald Trump's 2016 election campaign and Russia." Some had speculated that the White House would use "an ethics rule limiting government attorneys from investigating people their former law firm represented" to trip up Mueller's appointment. Jared Kushner is a client of Mueller's firm, WilmerHale. "Although Mueller has now been cleared by the Justice Department, the White House may still use his former law firm's connection to Manafort and Kushner to undermine the findings of his investigation, according to two sources close to the White House."